Hemraj singh sikarwar

@wise.global.research.services.1747

Indore

10+ Years of experience

SEBI Registration INH000016719

Trade Ideas

Opinions

Followers

Expertise

Quantitative

Growth

Technical

Index Strategies

Market Commentary

Futures & Options

Technical Analysis

Trade Facts

Total Trades

Missed Trades

Profit Trades

Accuracy

Ask me Anything

Got a question? Ask me and I will answer it. Stay curious, stay hungry!

Posts

shared an insight ⚡️ 11 hours ago

Dr. Reddy’s Laboratories stood out with strong performance.

The stock gained around 1.8% during Friday’s session, even as the Sensex and Nifty remained under pressure amid rising crude oil prices and heightened geopolitical concerns.

LALPATHLAB

The relative strength in the pharmaceutical sector is worth watching at a time when the broader market is facing multiple external headwinds. Brent crude moved above $108 per barrel, while concerns around inflation, bond yields and global interest rates weighed on overall investor sentiment. Dr. Reddy’s is a diversified pharmaceutical company with businesses spanning India, the US and other international markets. For investors tracking the stock, the key factors to monitor remain US business performance, product launches, regulatory developments, margins, earnings growth and currency movements Interestingly, despite Friday’s strength, the stock is still well below its recent 52-week high. This highlights an important point: **one strong trading session does not necessarily change the long-term investment thesis. In the current environment, relative strength can be useful for identifying stocks that are showing resilience when the broader market is weak. However, investors should distinguish between **short-term price momentum and sustainable fundamental improvement. What to watch next: • Quarterly earnings and margin trajectory • US generics/business performance • Regulatory developments • Volume and price behaviour • Valuation versus expected earnings growth Key takeaway:Dr. Reddy’s is showing relative resilience in a weak market, but the next move should ideally be evaluated through both **price action and fundamentals, rather than chasing a single-day gain. This post is for educational and informational purposes only and should not be construed as investment advice or a recommendation to buy or sell any security.

163

shared an insight ⚡️ 23 hours ago

ESDS Software Solution a Nashik-based data Centre

One of the most talked-about stocks in the market today is ESDS Software Solution, a Nashik-based data centre and cloud services company. The stock has attracted significant attention after an extraordinary post-listing rally. Listed on September 4, ESDS reportedly moved from around ₹429 to nearly ₹1,439 within just four trading sessions — a rise of more than 3x. The sharp move has also prompted a query from the BSE. The company operates in the data centre and cloud infrastructure space, a sector receiving increasing investor attention due to the rapid growth of AI, cloud computing and digital infrastructure. Adding to the market interest is the presence of well-known investors Ashish Kacholia and Mukul Agrawal, who held stakes in the company following its IPO. However, investors should remember that prominent shareholder participation alone does not establish an investment thesis. The bigger question now is valuation versus future growth. After the sharp rally, the stock is reportedly trading at a very high valuation, while investors will be watching the company's ability to convert its AI/data-centre opportunity into sustainable revenue and cash flows. For traders, such a sharp post-listing move can bring **very high volatility and price discovery risk**. For investors, the focus should be on business performance, valuation, cash flows, customer concentration and future earnings rather than simply chasing momentum. Key takeaway: A strong story and a hot sector can attract attention, but after a 3x move in a few sessions, risk management becomes equally important. This post is for educational and informational purposes only and should not be construed as investment advice or a recommendation to buy or sell any security.

ESDS

346

shared an insight ⚡️ 11th Sep

Cupid Limited Promoter Raises Stake With Fresh Buy

Cupid Limited

CUPID

promoter Aditya Kumar Halwasiya has bought an additional 15 lakh shares of the company through the open market, a transaction representing about 0.11% of the company's total share capital. Why Promoter Buying Gets Attention When a promoter increases their personal holding through open-market purchases, rather than through preferential allotments or ESOPs, it is often read by market participants as a signal of confidence in the company's near-term outlook, since the promoter is committing personal capital at prevailing market prices. Recent Business Performance Cupid, a manufacturer of male and female condoms, lubricants and in-vitro diagnostic kits that exports to more than 100 countries, reported a sharp jump in its most recent quarterly numbers, with net profit rising 215.03% year-on-year and sales rising 112.39% year-on-year for the quarter, continuing a period of strong re-rating for the stock over the past year. Stock Context Cupid shares have traded in a wide 52-week range, moving from a low near Rs 33 to a high close to Rs 299, reflecting the scale of the re-rating the stock has seen as its financial performance improved. Business Context Cupid Limited is headquartered in Nashik and has expanded in recent years from its core contraceptives business into diagnostics and personal-care products, including deodorants and hygiene items, as part of a broader diversification strategy. The company's production facility has an annual capacity of around 480 million male condoms, 52 million female condoms, and 210 million lubricant sachets. This update is based on exchange disclosures around the promoter transaction. It is not investment advice.

392

What are the top stock recommendations by Hemraj singh sikarwar?

Hemraj singh sikarwar regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include LALPATHLAB, ESDS and CUPID. Explore Hemraj singh sikarwar's complete list of posts and trade views on their StockGro profile.

How can I follow Hemraj singh sikarwar's latest investment insights?

You can follow Hemraj singh sikarwar's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.

What is Hemraj singh sikarwar's investment strategy?

Hemraj singh sikarwar follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.

How long has Hemraj singh sikarwar been a SEBI-registered Research Analyst (RA)?

Hemraj singh sikarwar has been a SEBI-registered Research Analyst and have 10+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.

Where can I see Hemraj singh sikarwar's past performance and stock picks?

You can check Hemraj singh sikarwar's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.

How can I contact Hemraj singh sikarwar for stock market advice?

For stock market guidance from Hemraj singh sikarwar, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.

What is Hemraj singh sikarwar's track record in predicting market movements?

Hemraj singh sikarwar has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.

What is the SEBI Registration number for Hemraj singh sikarwar?

Hemraj singh sikarwar is a SEBI-registered Research Analyst with the SEBI Registration INH000016719. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.

Be Financially Free with StockGro